Development and validation of a clinical-pharmacogenomic prediction model for clopidogrel-related high on-treatment platelet reactivity in patients with coronary artery disease.

Sun R, Du Y

Open source

DOI
10.3389/fcvm.2026.1926514
Published
2026
Container
Frontiers in cardiovascular medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fcvm.2026.1926514,
  title = {Development and validation of a clinical-pharmacogenomic prediction model for clopidogrel-related high on-treatment platelet reactivity in patients with coronary artery disease.},
  author = {Sun R and Du Y},
  year = {2026},
  journal = {Frontiers in cardiovascular medicine},
  doi = {10.3389/fcvm.2026.1926514},
  url = {https://doi.org/10.3389/fcvm.2026.1926514}
}

RIS

TY  - JOUR
TI  - Development and validation of a clinical-pharmacogenomic prediction model for clopidogrel-related high on-treatment platelet reactivity in patients with coronary artery disease.
AU  - Sun R
AU  - Du Y
PY  - 2026
JO  - Frontiers in cardiovascular medicine
DO  - 10.3389/fcvm.2026.1926514
UR  - https://doi.org/10.3389/fcvm.2026.1926514
ER  - 

APA

R, S., & Y, D. (2026). Development and validation of a clinical-pharmacogenomic prediction model for clopidogrel-related high on-treatment platelet reactivity in patients with coronary artery disease.. Frontiers in cardiovascular medicine. https://doi.org/10.3389/fcvm.2026.1926514

Source records